Chardan Healthcare Acquisition 2 Corp. Announces Pricing of $85 Million Initial Public Offering

NEW YORK, April 23, 2020 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE American: CHAQ.U, the "Company") announced today that it priced its initial public offering of 8,500,000 units at $10.00 per unit. The units are expected to be listed on NYSE American ("NYSE") and trade under the ticker symbol "CHAQ.U" beginning April 24, 2020. Each unit consists of one share of common stock and one warrant to purchase one-half of one share of common stock at an exercise price of $11.50 per whole share. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be listed on the NYSE under the symbols "CHAQ" and "CHAQ.WS" respectively.

The underwriters have been granted a 45-day option to purchase up to an additional 1,275,000 units offered by the Company to cover over-allotments.

The offering is expected to close on April 28, 2020, subject to customary closing conditions.

Chardan acted as sole book running manager in the offering.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on April 23, 2020. The offering is being made only by means of a prospectus, copies of which may be obtained by contacting Chardan Capital Markets, LLC, 17 State Street, 21st floor, New York, New York 10004. Copies of the registration statement can be accessed through the SEC's website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Chardan Healthcare Acquisition 2 Corp.

Chardan Healthcare Acquisition 2 Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although the Company intends to focus its search on a target businesses operating in North America in the healthcare industry.

Forward Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Contact:               

Chardan Healthcare Acquisition 2 Corp.
Jonas Grossman
President and CEO
17 State Street, 21^st Floor, New York, NY 10004
(646) 465-9000

SOURCE Chardan Capital Markets, LLC